ATXI

Avenue Therapeutics, Inc. Common Stock
ATXI

Overview Fund Activity
Delisted

ATXI was delisted on the 18th of March, 2025.

Back to rankings

14 hedge funds and large institutions have $5.51M invested in Avenue Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

Holders
14
Holders Change
+7
Holders Change %
+100%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OM
1
Opaleye Management
Massachusetts
$3.8M
2
EI
2
EAM Investors
California
$437K
3
SIM
3
Spark Investment Management
New York
$144K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$471K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$51K

Top Sellers

1
BRWA
1
B. Riley Wealth Advisors
Florida
$282K
2
BlackRock
2
BlackRock
New York
$80K
Name Market Value Shares Shares
Change 		Shares
Change %
OM
1
Opaleye Management
Massachusetts
$3.8M 800,000 +304,000 +61%
Vanguard Group
2
Vanguard Group
Pennsylvania
$471K 99,213 +29,052 +41%
EI
3
EAM Investors
California
$437K 91,966 +91,966 New
BRWA
4
B. Riley Wealth Advisors
Florida
$282K 59,250 -7,000 -11%
SIM
5
Spark Investment Management
New York
$144K 30,500 +30,500 New
FWM
6
Frontier Wealth Management
Missouri
$95K 20,000 – –
BlackRock
7
BlackRock
New York
$80K 16,939 -1,162 -6%
Northern Trust
8
Northern Trust
Illinois
$69K 14,568 – –
Deutsche Bank
9
Deutsche Bank
Germany
$51K 10,808 +10,808 New
Renaissance Technologies
10
Renaissance Technologies
New York
$51K 10,808 +10,808 New
UBS Group
11
UBS Group
Switzerland
$23K 4,785 +1,665 +53%
TRCT
12
Tower Research Capital (TRC)
New York
$2K 408 +408 New
Bank of America
13
Bank of America
North Carolina
$1K 187 +187 New
CFGS
14
Concourse Financial Group Securities
Alabama
– – – –
Barclays
15
Barclays
United Kingdom
$0 40 +40 New